Delivery Order SPE2DB20D3104-SPE2DB23FV3T0

Award Date 11/14/22
Potential Completion Date 11/15/22
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Menveo A-C-Y-W-135-DIP VIAL KTS. The contract has a ceiling value of $2,788.50 and was awarded on September 22, 2021, with a completion date of September 23, 2021. The contract is a delivery order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,686.95, is for the delivery of Menveo A-C-Y-W-135-DIP vial kits, a pharmaceutical product. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of March 29, 2022. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,243.40, is for the delivery of Menveo A-C-Y-W-135-DIP vial kits. It is a firm fixed-price delivery order contract with a period of performance ending on March 28, 2022. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award is for the delivery of pharmaceutical products and medical supplies, including Menveo A-C-Y-W-135-DIP vial kits, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,000.14, is a delivery order with a firm fixed-price pricing type. It has an ultimate completion date of March 25, 2022 and was awarded on March 24, 2022. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,044.25, is for the delivery of Menveo 1 vial-A-C-Y-W-135-DIP 0.5ML, a medical product. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans...
This federal contract award, valued at $2,435.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of 1 vial of the MENVEO A-C-Y-W-135-DIP vaccine. The contract has an ultimate completion date of April 25, 2024 and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Menveo A-C-Y-W kits (2 vials). The delivery order, valued at $10,816.56, was awarded on September 10, 2024 with an ultimate completion date of September 11, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award is for the delivery of Menveo A-C-Y-W kits (2 vials) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $1,608.45 and is a firm fixed-price delivery order with a period of performance through March 13, 2024. The contract was awarded on March 12, 2024 and does not have a set-aside designation, indicating it was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Menveo A-C-Y-W-135-DIP vial kits. The $3,373.90 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,357.20, is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS)S, which are likely medical products or vaccines. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV3T0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Menveo A-C-Y-W-135-DIP Vial Kits. The contract, valued at $2,224.32, is a firm fixed-price Delivery Order with a completion date of November 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov).

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 1:24 PM